[go: up one dir, main page]

RU2309156C2 - Агонисты окситоцина, их применение и содержащие их фармацевтические композиции - Google Patents

Агонисты окситоцина, их применение и содержащие их фармацевтические композиции Download PDF

Info

Publication number
RU2309156C2
RU2309156C2 RU2003136152/04A RU2003136152A RU2309156C2 RU 2309156 C2 RU2309156 C2 RU 2309156C2 RU 2003136152/04 A RU2003136152/04 A RU 2003136152/04A RU 2003136152 A RU2003136152 A RU 2003136152A RU 2309156 C2 RU2309156 C2 RU 2309156C2
Authority
RU
Russia
Prior art keywords
compound according
group
general formula
methyl
alkyl
Prior art date
Application number
RU2003136152/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2003136152A (ru
Inventor
Гэри Роберт Уиль м ПИТТ (GB)
Гэри Роберт Уильям Питт
Майкл Брайан РОУ (GB)
Майкл Брайан РОУ
Дейвид Филип РУКЕР (GB)
Дейвид Филип РУКЕР
Original Assignee
Ферринг Бв
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ферринг Бв filed Critical Ферринг Бв
Publication of RU2003136152A publication Critical patent/RU2003136152A/ru
Application granted granted Critical
Publication of RU2309156C2 publication Critical patent/RU2309156C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Tea And Coffee (AREA)
  • Current-Collector Devices For Electrically Propelled Vehicles (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
RU2003136152/04A 2001-06-25 2002-06-24 Агонисты окситоцина, их применение и содержащие их фармацевтические композиции RU2309156C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0115515.9A GB0115515D0 (en) 2001-06-25 2001-06-25 Oxytocin agonisys
GB0115515.9 2001-06-25

Publications (2)

Publication Number Publication Date
RU2003136152A RU2003136152A (ru) 2005-05-20
RU2309156C2 true RU2309156C2 (ru) 2007-10-27

Family

ID=9917320

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003136152/04A RU2309156C2 (ru) 2001-06-25 2002-06-24 Агонисты окситоцина, их применение и содержащие их фармацевтические композиции

Country Status (22)

Country Link
US (1) US20040235753A1 (fr)
EP (1) EP1399436B1 (fr)
JP (1) JP2005500317A (fr)
KR (1) KR20040010762A (fr)
CN (1) CN1606553A (fr)
AT (1) ATE291021T1 (fr)
CA (1) CA2450480A1 (fr)
CZ (1) CZ20033414A3 (fr)
DE (1) DE60203290T2 (fr)
DK (1) DK1399436T3 (fr)
ES (1) ES2239717T3 (fr)
GB (1) GB0115515D0 (fr)
HU (1) HUP0400368A3 (fr)
IL (1) IL159289A0 (fr)
MX (1) MXPA03011980A (fr)
NO (1) NO20035772L (fr)
NZ (1) NZ530035A (fr)
PL (1) PL367538A1 (fr)
PT (1) PT1399436E (fr)
RU (1) RU2309156C2 (fr)
WO (1) WO2003000692A2 (fr)
ZA (1) ZA200309626B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001082492A1 (fr) 2000-04-26 2001-11-01 Fujitsu Limited Appareil radiorecepteur et systeme de radiocommunications
DK1480998T3 (da) 2002-02-27 2007-03-26 Ferring Bv Mellemprodukter og fremgangsmåder til fremstilling af heptapeptidoxytocinanaloger
EP1449844A1 (fr) * 2003-02-14 2004-08-25 Ferring B.V. derives de benzamide agonistes de l'ocytocine et antagonistes de la vasopressine
EP1512687A1 (fr) * 2003-09-05 2005-03-09 Ferring B.V. Piperazines comme agonistes d'oxytocin
EP1632494A1 (fr) * 2004-08-24 2006-03-08 Ferring B.V. Antagonistes de la v1a vasopressine
CA2626180A1 (fr) * 2005-10-24 2007-05-03 Wyeth Methodes de traitement utilisant des agonistes du recepteur d'oxytocine
EP2146722A4 (fr) * 2007-05-10 2011-08-03 Amr Technology Inc Tétrahydrobenzo-l,4-diazépines substituées par un aryle ou un hétéroaryle et utilisation desdites dans le blocage de la réassimilation de la norépinéphrine, de la dopamine et de la sérotonine
UA98647C2 (en) * 2007-06-28 2012-06-11 Новартис Аг Kallikrein-7 modulators
WO2009033770A2 (fr) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
WO2009040006A1 (fr) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Spantide à usages thérapeutiques
WO2009033820A2 (fr) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
US20100204150A1 (en) * 2007-09-11 2010-08-12 Dorian Bevec Use of a peptide as a therapeutic agent
KR20100057641A (ko) * 2007-09-11 2010-05-31 몬도바이오테크 래보래토리즈 아게 인터메딘 47 및 53 펩티드의 치료적 용도
AR068509A1 (es) * 2007-09-19 2009-11-18 Jerini Ag Antagosnistas del receptor de bradiquinina b1
ES2595251T3 (es) 2010-05-25 2016-12-28 Inserm - Institut National De La Santé Et De La Recherche Médicale Métodos y composición farmacéutica para el tratamiento de un trastorno alimentario con inicio temprano en un paciente
GB201105537D0 (en) * 2011-03-31 2011-05-18 Vantia Ltd New process
CN103159641A (zh) * 2011-12-14 2013-06-19 天津泰普药品科技发展有限公司 托伐普坦中间体2-甲酸-5-(2-甲基苯甲酰氨基)甲苯的制备方法
EP3226688B1 (fr) * 2014-12-05 2020-07-01 Merck Sharp & Dohme Corp. Composés tricycliques servant d'inhibiteurs d'enzymes idh mutantes
KR102686349B1 (ko) * 2015-07-06 2024-07-17 키녹시스 테라퓨틱스 피티와이 리미티드 사회성 장애 및 물질 사용 장애의 치료를 위한 치료 화합물 및 조성물
EP4494705A3 (fr) * 2016-12-12 2025-04-02 Kinoxis Therapeutics Pty Ltd Agonistes de récepteur non peptidique d'oxytocine
KR20170035351A (ko) 2017-01-06 2017-03-30 셰플러코리아(유) 볼베어링용 케이지
EP4025221A4 (fr) * 2019-09-06 2024-01-03 Kinoxis Therapeutics Pty Ltd Traitement de sevrage des opioïdes
EP4378526A1 (fr) * 2022-11-30 2024-06-05 Université de Strasbourg Agonistes non peptidiques du recepteur de l'oxytocine
EP4378525A1 (fr) * 2022-11-30 2024-06-05 Université de Strasbourg Agonistes non peptidiques du recepteur de l'oxytocine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0469984A2 (fr) * 1990-07-31 1992-02-05 Sanofi Dérivés de la N-sulfonyl indoline, leur préparation, les compositions pharmaceutiques en contenant
WO2000046224A2 (fr) * 1999-02-04 2000-08-10 American Home Products Corporation N-oxydes de pyridine tricyclique en tant qu'agonistes de la vasopressine
RU2002120798A (ru) * 2000-01-05 2004-01-10 Ферринг Бв (Nl) Конденсированные азепины в качестве агонистов вазопрессина

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0469984A2 (fr) * 1990-07-31 1992-02-05 Sanofi Dérivés de la N-sulfonyl indoline, leur préparation, les compositions pharmaceutiques en contenant
WO2000046224A2 (fr) * 1999-02-04 2000-08-10 American Home Products Corporation N-oxydes de pyridine tricyclique en tant qu'agonistes de la vasopressine
RU2002120798A (ru) * 2000-01-05 2004-01-10 Ферринг Бв (Nl) Конденсированные азепины в качестве агонистов вазопрессина

Also Published As

Publication number Publication date
PT1399436E (pt) 2005-07-29
US20040235753A1 (en) 2004-11-25
IL159289A0 (en) 2004-06-01
CA2450480A1 (fr) 2003-01-03
MXPA03011980A (es) 2004-03-26
JP2005500317A (ja) 2005-01-06
CZ20033414A3 (en) 2004-05-12
EP1399436B1 (fr) 2005-03-16
EP1399436A2 (fr) 2004-03-24
ES2239717T3 (es) 2005-10-01
DE60203290D1 (de) 2005-04-21
ZA200309626B (en) 2004-05-12
ATE291021T1 (de) 2005-04-15
PL367538A1 (en) 2005-02-21
DE60203290T2 (de) 2006-02-02
KR20040010762A (ko) 2004-01-31
HK1064666A1 (en) 2005-02-04
WO2003000692A2 (fr) 2003-01-03
GB0115515D0 (en) 2001-08-15
CN1606553A (zh) 2005-04-13
NZ530035A (en) 2004-06-25
NO20035772L (no) 2003-12-22
RU2003136152A (ru) 2005-05-20
HUP0400368A3 (en) 2007-05-29
HUP0400368A2 (hu) 2004-08-30
DK1399436T3 (da) 2005-05-30
WO2003000692A3 (fr) 2003-05-15

Similar Documents

Publication Publication Date Title
RU2309156C2 (ru) Агонисты окситоцина, их применение и содержащие их фармацевтические композиции
RU2214400C2 (ru) Производные 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способы их получения, фармацевтическая композиция на их основе и промежуточные вещества
RU2336276C2 (ru) Пиперидиновые производные и способ их получения, применения, фармацевтическая композиция на их основе и способ лечения
RU2345996C1 (ru) Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
EA200600190A1 (ru) Производные пиримидин-2,4-диона в качестве антагонистов рецептора гонадотропин-высвобождающего гормона
BG100946A (bg) Нови аминокиселинни производни, метод за получаването им и фармацевтични състави съдържащи ги
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
HUP0203895A2 (hu) Szubsztituált azaindolok és ilyen vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
RU2000129161A (ru) Производное 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способ его получения, фармацевтическая композиция, содержащая указанное соединение, и промежуточный продукт
RU96104356A (ru) Производные амидина, обладающие активностью против синтетазы оксида азота (у)
JP2009504763A5 (fr)
RU2348628C2 (ru) Замещенные циклопропильной группой оксазолидиноновые антибиотики и их производные
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
RU2233273C3 (ru) Ароматические азотсодержащие 6-членные циклические соединения и фармацевтическая композиция
JP2019521988A5 (fr)
RU2007121219A (ru) Диазациклоалканы как агонисты окситоцина
RU2394031C2 (ru) Соли четвертичного аммония в качестве антагонистов м3
HUT77735A (hu) Triazinszármazékok és ezeket tartalmazó gyógyászati készítmények
AR045939A1 (es) Derivados de bencimidazolona y quinazolinona como agonistas de los receptores orl 1 humanos
JP2008503575A5 (fr)
RU2340617C2 (ru) Производные бензамида в качестве агонистов окситоцина и антагонистов вазопрессина
RU2003130070A (ru) Производные бигуанида
JPH05132430A (ja) 薬物従属症及び禁断症状の治療に関するグリシン/nmdaレセプターリガンドの用法
CN103025722B (zh) 具有2-(杂芳基)氨基取代基的氯苯吩嗪及其抗微生物活性
EA200600377A1 (ru) Новая композиция

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20090625